The low survival of patients with pancreatic ductal adenocarcinoma (PDAC) makes the
treatment of this disease one of the most challenging task in modern medicine. Here, by …

Pancreatic cancer (PC) is the deadliest malignancy due to late diagnosis. Aberrant
alterations in the blood proteome might serve as biomarkers to facilitate early detection of …

Background: Pancreatic cancer is highly lethal and aggressive with increasing trend of
mortality in both genders. An effective prediction model is needed to assess prognosis of …

Background Pancreatic adenocarcinoma (PC), is a type of digestive tract cancer with the
highest mortality all over the word, and its exact pathogenesis is not clear. Therefore, it is of …

Introduction Pancreatic adenocarcinoma (PAAD) is one of the most fatal cancers in the world
for early metastasis, extensive invasion, and poor prognosis with a 5‐year survival rate less …

Pyroptosis is an inflammatory programmed cell death, showing potentials to be a novel anti-
cancer approach. However, the roles of pyroptosis-related (PR) genes (PRGs) in pancreatic …

Predicting the prognosis of pancreatic cancer is important because of the very low survival
rates of patients with this particular cancer. Although several studies have used microRNA …

Pancreatic cancer (PC) is one of the most lethal malignancies with an extremely poor
prognosis. In this study, we aim to construct a long noncoding RNA (lncRNA)-based panel …

Pancreatic ductal adenocarcinoma (PDAC) is the most frequent and aggressive pancreatic
tumor characterized by high metastatic risk and special tumor microenvironment. To …

Background: Prostate cancer (PCa) is one of the most common tumors of the urinary system.
Cuproptosis is a novel mode of controlled cell death that is related to the development of …